Connect with us

Legal & Regulation

Cannabis Companies Call for FDA to Ease Medical Marijuana Rules

Jane Summers

Published

on

Call for FDA to Ease Cannabis Rules
- Ad -

The FDA is scheduled to hold its first public hearing today concerning the CBD industry. Ned Sharpless, a Food and Drug Administration Commissioner, commented on the meeting, stating

“There are real risks associated with [THC and CBD] and critical questions remain about the safety of their widespread use in foods and dietary supplements, as well as other consumer products — including cosmetics, which are subject to a separate regulatory framework.”

He added that the FDA is aware of the budding interest in the industry, but that the FDA is still working to evaluate how the pieces fit together, stating

“And given the new interest in marketing cannabis products across the range of areas FDA regulates, we will need to carefully evaluate how all these pieces fit together in terms of how consumers might access cannabis products,” Sharpless said.

“Nowhere is this truer than with CBD. While we have seen an explosion of interest in products containing CBD, there is still much that we don’t know.”

The meeting comes in at a time where companies are asking for an easing of cannabis rules. According to a New York Times article, many companies “will try to convince the F.D.A.” to let them sell their products in stores and online legally. At this point, the FDA has not decided anything, so the hope is that this meeting with provide some insight on the direction the FDA is leaning toward when it comes to defining standards for CBD.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com